chr15-28114598-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004667.6(HERC2):c.13913+14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.96 in 1,609,068 control chromosomes in the GnomAD database, including 751,615 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.85 ( 58175 hom., cov: 31)
Exomes 𝑓: 0.97 ( 693440 hom. )
Consequence
HERC2
NM_004667.6 intron
NM_004667.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.539
Genes affected
HERC2 (HGNC:4868): (HECT and RLD domain containing E3 ubiquitin protein ligase 2) This gene belongs to the HERC gene family that encodes a group of unusually large proteins, which contain multiple structural domains. All members have at least 1 copy of an N-terminal region showing homology to the cell cycle regulator RCC1 and a C-terminal HECT (homologous to E6-AP C terminus) domain found in a number of E3 ubiquitin protein ligases. Genetic variations in this gene are associated with skin/hair/eye pigmentation variability. Multiple pseudogenes of this gene are located on chromosomes 15 and 16. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 15-28114598-G-A is Benign according to our data. Variant chr15-28114598-G-A is described in ClinVar as [Benign]. Clinvar id is 1285341.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.987 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HERC2 | NM_004667.6 | c.13913+14C>T | intron_variant | ENST00000261609.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HERC2 | ENST00000261609.13 | c.13913+14C>T | intron_variant | 1 | NM_004667.6 | P1 | |||
HERC2 | ENST00000566635.5 | n.1038+14C>T | intron_variant, non_coding_transcript_variant | 1 | |||||
HERC2 | ENST00000650509.1 | c.*1027+14C>T | intron_variant, NMD_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.849 AC: 128910AN: 151902Hom.: 58175 Cov.: 31
GnomAD3 genomes
AF:
AC:
128910
AN:
151902
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.938 AC: 233938AN: 249496Hom.: 111720 AF XY: 0.942 AC XY: 127075AN XY: 134906
GnomAD3 exomes
AF:
AC:
233938
AN:
249496
Hom.:
AF XY:
AC XY:
127075
AN XY:
134906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.972 AC: 1416156AN: 1457048Hom.: 693440 Cov.: 37 AF XY: 0.970 AC XY: 702478AN XY: 724050
GnomAD4 exome
AF:
AC:
1416156
AN:
1457048
Hom.:
Cov.:
37
AF XY:
AC XY:
702478
AN XY:
724050
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.848 AC: 128941AN: 152020Hom.: 58175 Cov.: 31 AF XY: 0.852 AC XY: 63279AN XY: 74310
GnomAD4 genome
AF:
AC:
128941
AN:
152020
Hom.:
Cov.:
31
AF XY:
AC XY:
63279
AN XY:
74310
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3045
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Developmental delay with autism spectrum disorder and gait instability Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at